Kakao Healthcare signed a memorandum of understanding (MOU) with Sanofi-Aventis Korea on April 6, 2026, to conduct real-world evidence (RWE) research and develop AI solutions using medical data.13
The MOU was signed during the Korea-France Economic Future Dialogue, marking the 140th anniversary of diplomatic ties between Korea and France.12
The partnership involves joint RWE studies with healthcare data and advancing AI models through federated learning, a method that trains models without transferring data externally to protect privacy.12
Kakao Healthcare provides platforms and technologies for real clinical data research, while Sanofi contributes AI, digital healthcare, and medical expertise.12
Applications include early detection of diseases like Fabry disease and personalized management for conditions such as asthma.1
Quotes:
Sanofi-Aventis Korea GM Bae Kyung-eun highlighted it as a starting point for advancing clinical research; Kakao Healthcare CEO Hwang Hee emphasized implementing RWE in clinical settings.12
Sources:
1. https://www.koreatimes.co.kr/business/20260406/kakao-healthcare-sanofi-partner-to-harness-medical-data-for-ai-solutions
2. https://en.sedaily.com/culture/2026/04/06/kakao-healthcare-sanofi-join-hands-on-ai-cooperation
3. https://letsdatascience.com/news/kakao-healthcare-partners-with-sanofi-for-ai-solutions-c17d4692